Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation

Recruiting Observational Study
Coronary Artery Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
12,000 (estimated)
Sponsor
Cathreine BV · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
To achieve optimal long-term clinical results after percutaneous coronary intervention (PCI), adequate deployment of stents is essential. Thorough expansion of the stent and full apposition of stent struts against the vessel wall are determining factors for preventing stent thrombosis and restenosis for bare-metal as well as drug-eluting stents (DES). Standard coronary angiography is limited in as…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients \>18 years old who undergo PCI for any indication are included in the register of the Netherlands Heart Registration and therefore included in the final analysis of this project Exclusion Criteria: \- If a patient has multiple PCIs within 365 days, only the firs…
Contacts

K Teeuwen, MD, PhD

+ 31 040 239 9111

koen.teeuwen@catharinaziekenhuis.nl

CONTACT

K.A.J. Beek, MD

+ 31 040 239 9111

konrad.v.beek@catharinaziekenhuis.nl

CONTACT